Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.

Related Keywords

India , China , Eli Lilly , Las Vegas , Doug Long , Product Launches Research , National Prescription Audit , National Sales Perspective , Health Services Utilization Index , Novo Nordisk , National Sales Perspectives , Johnson , Specialty Pharmaceutical Trends , Look Ahead , Services Utilization Index , Spending Trends , Shortages Database , Sales Perspective , Landscape Tracker , Launch Excellence , Axs24 , Asembia , Iqvia ,